ArticleMolecular oncology2014

CPSF4 activates telomerase reverse transcriptase and predicts poor prognosis in human lung adenocarcinomas.

Wangbing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.